These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 23953269)

  • 1. A proof of concept study of tolcapone for pathological gambling: relationships with COMT genotype and brain activation.
    Grant JE; Odlaug BL; Chamberlain SR; Hampshire A; Schreiber LR; Kim SW
    Eur Neuropsychopharmacol; 2013 Nov; 23(11):1587-96. PubMed ID: 23953269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolcapone improves cognition and cortical information processing in normal human subjects.
    Apud JA; Mattay V; Chen J; Kolachana BS; Callicott JH; Rasetti R; Alce G; Iudicello JE; Akbar N; Egan MF; Goldberg TE; Weinberger DR
    Neuropsychopharmacology; 2007 May; 32(5):1011-20. PubMed ID: 17063156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of prepulse inhibition and executive function by the COMT inhibitor tolcapone depends on COMT Val158Met polymorphism.
    Giakoumaki SG; Roussos P; Bitsios P
    Neuropsychopharmacology; 2008 Dec; 33(13):3058-68. PubMed ID: 18536698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of tolcapone on working memory and brain activity in abstinent smokers: a proof-of-concept study.
    Ashare RL; Wileyto EP; Ruparel K; Goelz PM; Hopson RD; Valdez JN; Gur RC; Loughead J; Lerman C
    Drug Alcohol Depend; 2013 Dec; 133(3):852-6. PubMed ID: 24095246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COMT Val(158)Met genotype determines the direction of cognitive effects produced by catechol-O-methyltransferase inhibition.
    Farrell SM; Tunbridge EM; Braeutigam S; Harrison PJ
    Biol Psychiatry; 2012 Mar; 71(6):538-44. PubMed ID: 22364739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotype-Dependent Effects of COMT Inhibition on Cognitive Function in a Highly Specific, Novel Mouse Model of Altered COMT Activity.
    Barkus C; Korn C; Stumpenhorst K; Laatikainen LM; Ballard D; Lee S; Sharp T; Harrison PJ; Bannerman DM; Weinberger DR; Chen J; Tunbridge EM
    Neuropsychopharmacology; 2016 Dec; 41(13):3060-3069. PubMed ID: 27388330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolcapone effects on gating, working memory, and mood interact with the synonymous catechol-O-methyltransferase rs4818c/g polymorphism.
    Roussos P; Giakoumaki SG; Bitsios P
    Biol Psychiatry; 2009 Dec; 66(11):997-1004. PubMed ID: 19699472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Replacing a dopamine agonist by the COMT-inhibitor tolcapone as an adjunct to L-dopa in the treatment of Parkinson's disease: a randomized, multicenter, open-label, parallel-group study.
    Ries V; Selzer R; Eichhorn T; Oertel WH; Eggert K;
    Clin Neuropharmacol; 2010 May; 33(3):142-50. PubMed ID: 20502133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolcapone, COMT polymorphisms and pharmacogenomic treatment of schizophrenia.
    Bitsios P; Roussos P
    Pharmacogenomics; 2011 Apr; 12(4):559-66. PubMed ID: 21521027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between COMT genotype and the clinical effectiveness of tolcapone, a COMT inhibitor, in patients with Parkinson's disease.
    Chong DJ; Suchowersky O; Szumlanski C; Weinshilboum RM; Brant R; Campbell NR
    Clin Neuropharmacol; 2000; 23(3):143-8. PubMed ID: 10895397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain catechol-O-methyltransferase (COMT) inhibition by tolcapone counteracts recognition memory deficits in normal and chronic phencyclidine-treated rats and in COMT-Val transgenic mice.
    Detrait ER; Carr GV; Weinberger DR; Lamberty Y
    Behav Pharmacol; 2016 Aug; 27(5):415-21. PubMed ID: 26919286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of tolcapone on brain activity during a variable attentional control task: a double-blind, placebo-controlled, counter-balanced trial in healthy volunteers.
    Magalona SC; Rasetti R; Chen J; Chen Q; Gold I; Decot H; Callicott JH; Berman KF; Apud JA; Weinberger DR; Mattay VS
    CNS Drugs; 2013 Aug; 27(8):663-73. PubMed ID: 23794107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Right inferior frontal cortex activity correlates with tolcapone responsivity in problem and pathological gamblers.
    Kayser AS; Vega T; Weinstein D; Peters J; Mitchell JM
    Neuroimage Clin; 2017; 13():339-348. PubMed ID: 28066708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolcapone enhances food-evoked dopamine efflux and executive memory processes mediated by the rat prefrontal cortex.
    Lapish CC; Ahn S; Evangelista LM; So K; Seamans JK; Phillips AG
    Psychopharmacology (Berl); 2009 Jan; 202(1-3):521-30. PubMed ID: 18854987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COMT genotype, gambling activity, and cognition.
    Grant JE; Leppink EW; Redden SA; Odlaug BL; Chamberlain SR
    J Psychiatr Res; 2015 Sep; 68():371-6. PubMed ID: 26028545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing levodopa pharmacokinetics with multiple tolcapone doses in the elderly.
    Jorga KM; Sedek G; Fotteler B; Zürcher G; Nielsen T; Aitken JW
    Clin Pharmacol Ther; 1997 Sep; 62(3):300-10. PubMed ID: 9333106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the tight-binding nature of tolcapone inhibition of soluble and membrane-bound rat brain catechol-O-methyltransferase.
    Borges N; Vieira-Coelho MA; Parada A; Soares-da-Silva P
    J Pharmacol Exp Ther; 1997 Aug; 282(2):812-7. PubMed ID: 9262345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catechol-O-Methyltransferase inhibition and alcohol use disorder: Evaluating the efficacy of tolcapone in ethanol-dependent rats.
    Doyle MR; Dirik S; Martinez AR; Hughes TE; Iyer MR; Sneddon EA; Seo H; Cohen SM; de Guglielmo G
    Neuropharmacology; 2024 Jan; 242():109770. PubMed ID: 37858886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolcapone-Enhanced Neurocognition in Healthy Adults: Neural Basis and Predictors.
    Bhakta SG; Light GA; Talledo JA; Balvaneda B; Hughes E; Alvarez A; Rana BK; Young JW; Swerdlow NR
    Int J Neuropsychopharmacol; 2017 Dec; 20(12):979-987. PubMed ID: 29020372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased connectivity of the default mode network in pathological gambling: a resting state functional MRI study.
    Jung MH; Kim JH; Shin YC; Jung WH; Jang JH; Choi JS; Kang DH; Yi JS; Choi CH; Kwon JS
    Neurosci Lett; 2014 Nov; 583():120-5. PubMed ID: 25238959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.